Ipsen is a Global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases and improving quality of life patients.
Ipsen is a global biopharmaceutical group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
IPSEN IS A GROWTH STORY
Pact & Partners is a Global Executive Search firm, specialized in Life Sciences. We are the best transatlantic recruiter in the sector and have gained our expertise by working on International and Local recruitments across the States and Europe since 1987.
We have experience recruiting top talents in General Management, Sales & Marketing, R&D, Clinical Development & Manufacturing, as well as all Executive & support functions.
Whether you are looking to reinforce your teams or expand abroad, our international team of consultants is here to support you in your development.
The Dassault Systèmes (DS) vision is to enable everyone—from designers to consumers and their communities—to create, share, and experience in 3D. As a world leader in 3D and Product Lifecycle Management (PLM) solutions, the company’s software and services allow businesses of any size in any industry around the globe to digitally define and simulate products, as well as the processes and resources required to manufacture, maintain, and recycle them while sustaining our environment.
McDermott Will & Emery is a leading international law firm with a diversified business practice. Currently numbering more than 1,000 lawyers, we have 20 officesworldwide, including in Paris and Boston, and a strategic alliance with MWE China Law Offices in Shanghai. McDermott has more than 80 years of experience serving a broad range of clientinterests. Our diversified business practice enables us to represent a wide range of commercial, industrial and financial enterprises, both publicly and privatelyheld. Our clientele include some of the world’s largest corporations, small and medium-sized businesses, and individuals. Outstanding client service is a cornerstone of our practice that has withstood the test of geography, economy and time. We are proud of the recognition we have received from our clients for our commitment to service, and we value their satisfaction as the best measure of our success.
Essilor is the leading manufacturer and wholesale distributor of optical lenses in the United States. In 1996, with the establishment of Essilor Laboratories of America, Inc. (Essilor Labs), Essilor became the first fully integrated optical company in the United States, specializing in ophthalmic lens production, manufacturing and distribution in addition to wholesale optical laboratory operations.
Natixis Investment Managers is a global asset management company. The company has headquarters in Paris and Boston and it is the second biggest French manager by market share.
Natixis Investment Managers serves financial professionals with more insightful ways to construct portfolios. Powered by the expertise of 26 specialized investment managers globally, we apply Active Thinking℠ to deliver proactive solutions that help clients pursue better outcomes in all markets. Natixis ranks among the world’s largest asset management firms1 ($988.4 billion AUM2).
Since 1990, Axelia provides consulting and financial services to small and medium-sized European companies that plan to establish or have established an operation anywhere in the United States.
Visiomed was founded by Eric Sebban, who had one strong conviction :
that market need is what drives a product’s relevance, not vice versa.In order to address some of his own health issues, Sebban decided in 2004 to use his twenty years of electronics expertise to serve the wider medical community.In 2007, after three years of research and development ThermoFlash® is put on the market. It is the world’s first easy-to-use, reliable, and accurate touchless thermometer. Visiomed is born and its first product is brought to market with the support of healthcare professionals such as doctors and pharmacists.Visiomed Group begins to design, develop and market a range of electronic “smart and connected devices” in the field of medical self-diagnosis.
In 2013, BioMérieux celebrated a major milestone, our 50th anniversary. Our development during these years has been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. Today, in more than 150 countries through 42 subsidiaries and a large network of distributors, bioMérieux provides diagnostic solutions that improve patient health and ensure consumer safety. We develop tests that bring high medical value for clinical decisions in the areas of infectious diseases, cardiovascular emergencies and targeted cancers. In industrial applications, we contribute to preventing contamination risks in agri-food, pharmaceutical and cosmetic products.We also bring progress to laboratories: by increasing automation and improving data management, we are helping to reinforce the efficiency of healthcare structures, increase lab productivity, and reduce healthcare costs. BioMérieux is determined to continue to play a pioneering role by innovating and designing the diagnostics of the future to address the major challenges for public health worldwide.
The French Tech Hub (the Hub) is a growth accelerator for French High Tech Companies in the U.S. The French Tech Hub has formed an alliance with UBIFRANCE to serve IT and Life Sciences companies from all over France. The French Tech Hub is located in San Francisco and in Boston and operates as a One-Stop-Shop to provide a wide variety of services needed for American expansion: strategic coaching, marketing support, business development, domiciliation, working desk, subsidiary creation, administrative support, etc. The French Tech Hub was founded as an initiative of the Paris Region Development Agency, the French Ministry of Foreign Trade, UBIFRANCE and BPIFrance.
Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
Sullivan & Worcester is a leading corporate law firm advising clients ranging from Fortune 500 companies to emerging businesses. With more than 185 lawyers in Boston, London, New York and Washington, D.C., the firm offers services in a wide range of areas, including corporate finance, banking, trade finance, securities and mutual funds, litigation, mergers and acquisitions, tax, real estate and REITs, private equity and venture capital, bankruptcy, environment and natural resources, climate change, renewable energy and water resources, regulatory law, and employment and benefits.
Veolia Energy is a leading international provider of custom, sustainable energy services and facility operations and management solutions. From diagnostic analyses and recommendations to energy procurement and conversion, facility operations and management, and technical, financial and human resources engineering, all of our services can be assimilated into a comprehensive package.
© 2018 FACC NEW ENGLAND